Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leupromer versus Eligard in metastatic prostate cancer
IRCT201206131030N10Phase 3Completed
- Sponsor
- Iran Polymer and Petrochemical Institute
- Start
- Nov 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of leuprolide in Metastatic Prostate Cancer (mPC) (2 arms), sponsored by Iran Polymer and Petrochemical Institute. Started Nov 2012; status: completed.
02
Drugs
leuprolide
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on IRCT201206131030N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206131030N10.